Search results for "Microenvironment"

showing 10 items of 369 documents

CCL27 Signaling in the Tumor Microenvironment

2021

Chemokines are a group of small proteins which play an important role in leukocyte migration and invasion. They are also involved in the cellular proliferation and migration of tumor cells.Chemokine CCL27 (cutaneous T cell-attracting chemokine, CTACK) is mainly expressed by keratinocytes of the normal epidermis. It is well known that this chemokine plays an important role in several inflammatory diseases of the skin, such as atopic dermatitis, contact dermatitis, and psoriasis. Moreover, several studies have shown an association between CCL27 expression and a variety of neoplasms including skin cancer.In this chapter, we address the role of chemokine CCL27 in the tumor microenvironment in t…

ChemokineLeukocyte migrationTumor microenvironmentChemokine receptorbiologymedicinebiology.proteinCancer researchCCL27CCR10Atopic dermatitisSkin cancermedicine.disease
researchProduct

ROLE OF EXOSOMES RELEASED BY CHRONIC MYELOGENOUS LEUKEMIA CELLS IN THE CROSS-TALK WITH ENDOTHELIAL CELLS

2016

Chronic myelogenous leukemia; exosomes; tumor microenvironment; curcuminexosometumor microenvironmentcurcuminHuman medicineChronic myelogenous leukemia
researchProduct

Proteomic profiling and functional characterization of metastatic colon cancer exosomes spreading malignant properties in tumor microenvironment

2016

Human tumors display a remarkable intratumor heterogeneity affecting clinically relevant phenotypes such as ability to metastasize or to tolerate cytotoxic drugs. Recent published data indicate that tumor derived exosomes (TDEs) can have a pivotal role in regulating tumor heterogeneity by transferring functional biomolecules between various populations of tumor cells and between tumor cells and nontumor cells with consequences for whole tumor microenvironment. In this context, our goal was to understand if exosomes derived from highly metastatic cell line may influence the behaviour of less aggressive tumor cells and the properties of endhothelium.

Colon cancer exosomeproteomicsSettore BIO/13 - Biologia Applicatatumor microenvironment
researchProduct

Unraveling the extracellular matrix-tumor cell interactions to aid better targeted therapies for neuroblastoma

2021

Treatment in children with high-risk neuroblastoma remains largely unsuccessful due to the development of metastases and drug resistance. The biological complexity of these tumors and their microenvironment represent one of the many challenges to face. Matrix glycoproteins such as vitronectin act as bridge elements between extracellular matrix and tumor cells and can promote tumor cell spreading. In this study, we established through a clinical cohort and preclinical models that the interaction of vitronectin and its ligands, such as αv integrins, are related to the stiffness of the extracellular matrix in high-risk neuroblastoma. These marked alterations found in the matrix led us to speci…

Combination therapyPharmaceutical ScienceCilengitideAntineoplastic AgentsCell CommunicationExtracellular matrixchemistry.chemical_compoundNeuroblastomaNeuroblastomamedicineTumor MicroenvironmentHumansVitronectinEtoposideEtoposidechemistry.chemical_classificationTumor microenvironmentbiologyCilengitidemedicine.diseaseExtracellular MatrixNanomedicinechemistryTumor microenvironmentbiology.proteinCancer researchVitronectinGlycoproteinmedicine.drug
researchProduct

Therapeutic afucosylated monoclonal antibody and bispecific T-cell engagers for T-cell acute lymphoblastic leukemia

2021

BackgroundT-cell acute lymphoblastic leukemia (T-ALL) is an aggressive disease with a poor cure rate for relapsed/resistant patients. Due to the lack of T-cell restricted targetable antigens, effective immune-therapeutics are not presently available and the treatment of chemo-refractory T-ALL is still an unmet clinical need. To develop novel immune-therapy for T-ALL, we generated an afucosylated monoclonal antibody (mAb) (ahuUMG1) and two different bispecific T-cell engagers (BTCEs) against UMG1, a unique CD43-epitope highly and selectively expressed by T-ALL cells from pediatric and adult patients.MethodsUMG1 expression was assessed by immunohistochemistry (IHC) on a wide panel of normal t…

Cytotoxicity ImmunologicCancer Research2434T-LymphocytesMice SCIDafucosylated monoclonal antibodyLymphocyte ActivationPrecursor T-Cell Lymphoblastic Leukemia-LymphomaEpitopesJurkat CellsAntineoplastic Agents ImmunologicalAntibody SpecificityMice Inbred NODantigensAntibodies BispecificTumor MicroenvironmentImmunology and Allergyantibodieshematologic neoplasms1506RC254-282Antibody-dependent cell-mediated cytotoxicityLeukosialinbispecific T-cell engagersmedicine.diagnostic_testbiologyhematological malignancieNeoplasms. Tumors. Oncology. Including cancer and carcinogensmedicine.anatomical_structureantibodieOncologytranslational medical researchMolecular MedicineImmunohistochemistryFemaleimmunotherapyAntibodyT-ALLT-cell engagersT-cell acute lymphoblastic leukemiamedicine.drug_classT cellImmunologySettore MED/08 - Anatomia PatologicaMonoclonal antibodyAntibodies Monoclonal HumanizedFlow cytometryT Acute Lymphoblastic LeukemiaantigenAntigenPhagocytosismedicineAnimalsHumanshematological malignanciesCell ProliferationPharmacologyT-cell engagerbusiness.industryhematological malignancies; antibodies; antigens; hematologic neoplasms; immunotherapy; neoplasm; T-ALL; T-cell engagers; translational medical research; translational researchBasic Tumor ImmunologyXenograft Model Antitumor Assaystranslational researchCancer researchbiology.proteinneoplasmbusinesshematologic neoplasmneoplasm
researchProduct

γδ T cell-based anticancer immunotherapy: Progress and possibilities

2015

Cytotoxicity Immunologicmedicine.medical_treatmentT cellT-LymphocytesImmunologyImmunotherapy AdoptiveInterferon-gammaNeoplasmsTumor MicroenvironmentImmunology and AllergyMedicineAnimalsHumansSettore MED/04 - Patologia GeneraleTumor microenvironmentTumor-infiltrating lymphocytesbusiness.industryInterleukin-17Neoplasms therapyReceptors Antigen T-Cell gamma-deltaImmunotherapymedicine.anatomical_structureγδ T cells • cancer • IFN-γ • IL-17 • immunotherapy • PD-1 • tumor-infiltrating lymphocytesOncologyImmunologySettore MED/46 - Scienze Tecniche Di Medicina Di Laboratoriobusiness
researchProduct

Corrigendum: Dissection of DLBCL microenvironment provides a gene expression-based predictor of survival applicable to formalin-fixed paraffin-embedd…

2019

The affiliations of authors T. Venesio and A. Sapino were originally incorrect. These have now been corrected as per the author listing above.

DLBCL microenvironment gene expression DLBCL
researchProduct

Versican and Tumor-Associated Macrophages Promotes Tumor Progression and Metastasis in Canine and Murine Models of Breast Carcinoma

2019

Versican and tumor-associated macrophages (TAMs) are involved in growth and metastases in several cancers. Here, we investigated the potential role of versican, a matrix proteoglycan, and its correlation with TAMs infiltrates in different stages of two different breast cancer models: spontaneous canine mammary gland carcinomas and the murine 4T1 breast cancer model. The stromal versican expression was correlated with TAMs accumulation in tumors with an advanced stage from spontaneous canine mammary carcinoma samples. Versican expression in mice, identified in late stages of tumor progression, was associated to a high number of peri-tumoral infiltrating TAMs. Indeed, TAMs were related to a p…

EXPRESSION0301 basic medicineCancer ResearchStromal cellMICROENVIRONMENTlcsh:RC254-282Metastasis03 medical and health sciencesangiogenesis0302 clinical medicineBreast cancerbreast cancerINFLAMMATIONstomatognathic systemEXTRACELLULAR-MATRIXmedicineTGF-BETA-1skin and connective tissue diseasesOriginal ResearchversicanCanine Mammary CarcinomaScience & Technologybiologybusiness.industrytumor-associated macrophageslung metastasisTGF-BETAmedicine.diseaselcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogensCANCERPrimary tumorcarbohydrates (lipids)030104 developmental biologyOncologyTumor progression030220 oncology & carcinogenesisCELLSbiology.proteinCancer researchGROWTHVersicanBreast carcinomabusinessLife Sciences & BiomedicineCCL2hormones hormone substitutes and hormone antagonistsFrontiers in Oncology
researchProduct

Loss of histone macroH2A1 in hepatocellular carcinoma cells promotes paracrine-mediated chemoresistance and CD4+CD25+FoxP3+ regulatory T cells activa…

2020

Rationale: Loss of histone macroH2A1 induces appearance of cancer stem cells (CSCs)-like cells in hepatocellular carcinoma (HCC). How CSCs interact with the tumor microenvironment and the adaptive immune system is unclear. Methods: We screened aggressive human HCC for macroH2A1 and CD44 CSC marker expression. We also knocked down (KD) macroH2A1 in HCC cells, and performed integrated transcriptomic and secretomic analyses. Results: Human HCC showed low macroH2A1 and high CD44 expression compared to control tissues. MacroH2A1 KD CSC-like cells transferred paracrinally their chemoresistant properties to parental HCC cells. MacroH2A1 KD conditioned media transcriptionally reprogrammed parental …

EXPRESSION0301 basic medicineLIVERAdaptive immune systemPOSTTRANSCRIPTIONAL CONTROLHepatocellular carcinomaMedicine (miscellaneous)PROGRESSIONHistone macroH2A1Research & Experimental MedicineCONTRIBUTES03 medical and health sciencesParacrine signalling0302 clinical medicineadaptive immune systemCancer stem cellCANCER STEM-CELLSmedicinechemoresistance.TRANSCRIPTIONIL-2 receptorneoplasmsPharmacology Toxicology and Pharmaceutics (miscellaneous)Tumor microenvironmentScience & Technologybiologyhistone macroH2A1CD44PROLIFERATIONchemoresistanceCancerFOXP3hepatocellular carcinomamedicine.diseaseAcquired immune systemdigestive system diseases3. Good healthCYTOKINE030104 developmental biologyMedicine Research & ExperimentalSENESCENCE030220 oncology & carcinogenesisCancer researchbiology.proteinLife Sciences & BiomedicineChemoresistance
researchProduct

Microglial activation milieu controls regulatory T cell responses.

2013

Abstract Although mechanisms leading to brain-specific inflammation and T cell activation have been widely investigated, regulatory mechanisms of local innate immune cells in the brain are only poorly understood. In this study, to our knowledge we show for the first time that MHC class II+CD40dimCD86dimIL-10+ microglia are potent inducers of Ag-specific CD4+Foxp3+ regulatory T cells (Tregs) in vitro. Microglia differentially regulated MHC class II expression, costimulatory molecules, and IL-10 depending on the amount of IFN-γ challenge and Ag dose, promoting either effector T cell or Treg induction. Microglia-induced Tregs were functionally active in vitro by inhibiting Ag-specific prolifer…

Encephalomyelitis Autoimmune ExperimentalRegulatory T cellT cellImmunologychemical and pharmacologic phenomenaMice TransgenicLymphocyte ActivationT-Lymphocytes RegulatoryImmune toleranceInterferon-gammaMiceImmune systemT-Lymphocyte SubsetsmedicineImmune ToleranceImmunology and AllergyAnimalsCells CulturedCD86MHC class IIbiologyMicrogliaHistocompatibility Antigens Class IIFOXP3Brainhemic and immune systemsForkhead Transcription FactorsCoculture TechniquesCell biologyInterleukin-10Mice Inbred C57BLmedicine.anatomical_structureCellular Microenvironmentbiology.proteinMicrogliaJournal of immunology (Baltimore, Md. : 1950)
researchProduct